In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, provide a June 2024 update focusing on a trio of topics across the spectrum of diabetes management.

In the episode, hosts discuss the US Food and Drug Administration clearance of 2 new over-the-counter continuous glucose monitoring systems from Abbott, the renaming of JDRF to Breakthrough T1D, and the FDA clearance of the CamAPS FX for people with type 1 diabetes.

Chapters: 
00:00 - Intro
00:40 - Abbott OTC CGM
06:20 - Diabetes Technology Pipeline
10:45 - JDRF Rebrands as Breakthrough T1D
15:15 -  US FDA Clearance of CamAPS FX